Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis
Open Access
- 1 July 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 15 (7) , 1062-1070
Abstract
Background. Recent reports suggest that the preoperative use of infliximab (IFX) increases postoperative infectious complications in patients with ulcerative coKeywords
This publication has 21 references indexed in Scilit:
- Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative ProctocolectomyDiseases of the Colon & Rectum, 2008
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Inflammatory bowel disease: clinical aspects and established and evolving therapiesThe Lancet, 2007
- Effect of Infliximab on Short-Term Complications in Patients Undergoing Operation for Chronic Ulcerative ColitisJournal of the American College of Surgeons, 2007
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Early Postoperative Complications are not Increased in Patients with Crohn's Disease Treated Perioperatively with Infliximab or Immunosuppressive TherapyAmerican Journal of Gastroenterology, 2004
- The risk of post‐operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort studyAlimentary Pharmacology & Therapeutics, 2004
- IIeal Pouch-Anal Anastomoses Complications and Function in 1005 PatientsAnnals of Surgery, 1995
- Surgery for ulcerative colitis in the era of the pouch: the St Mark's Hospital experience.Gut, 1994
- Colorectal cancer risk and mortality in patients with ulcerative colitisGastroenterology, 1992